Literature DB >> 12210493

Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells.

Gary Z Morris1, Roy L Williams, Mark S Elliott, Stephen J Beebe.   

Abstract

BACKGROUND: This study was conducted to determine the effects of resveratrol on prostate cancer cell viability through apoptosis induction and the significance of the three hydroxyl groups on resveratrol to the measured effect.
METHODS: Hormone-sensitive LNCaP cells and hormone-insensitive DU 145 cells were treated with resveratrol, tri-methoxy-resveratrol, or diethylstilbestrol (DES; the positive control for toxicity and apoptosis). Cell viability was determined by using an MTS assay. Apoptosis was determined by the appearance of apoptotic morphology, annexin V-FITC-positive intact cells, and caspase activation.
RESULTS: Resveratrol and DES decreased viability in LNCaP cells, but only resveratrol-treated cells expressed apoptotic morphology, annexin V-FITC-positive cells, and caspase activation. Tri-methoxy-resveratrol had no effect on DU 145 cell-viability and was less toxic to LNCaP cells than resveratrol.
CONCLUSION: Resveratrol was toxic to cells regardless of whether the cells were hormone-responsive or -unresponsive. This finding suggests that the cell's hormone responsive status is not an important determinant of the response to resveratrol. Furthermore, the hydroxyl-groups on resveratrol are required for cell toxicity. Finally resveratrol but not DES induced caspase-mediated apoptosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210493     DOI: 10.1002/pros.10122

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

1.  Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography.

Authors:  Zhirong Wang; Tze-chen Hsieh; Zhongtao Zhang; Yuliang Ma; Joseph M Wu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

2.  The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention.

Authors:  Maarten C Bosland
Journal:  Rev Urol       Date:  2005

Review 3.  Lifestyle issues and genitourinary tumours.

Authors:  Frank Sommer; Theo Klotz; Bernd J Schmitz-Dräger
Journal:  World J Urol       Date:  2003-12-12       Impact factor: 4.226

4.  Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells.

Authors:  Hao Jiang; Xia Shang; Hongtao Wu; Grace Huang; Yiyang Wang; Shaza Al-Holou; Subhash C Gautam; Michael Chopp
Journal:  Neurochem Res       Date:  2009-08-15       Impact factor: 3.996

5.  The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells.

Authors:  Mar Larrosa; Francisco A Tomás-Barberán; Juan Carlos Espín
Journal:  Eur J Nutr       Date:  2004-01-12       Impact factor: 5.614

Review 6.  [A critical assessment of phytotherapy for prostate cancer].

Authors:  F G E Perabo; E C von Löw; R Siener; J Ellinger; S C Müller; P J Bastian
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

7.  Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells.

Authors:  Sankarathi Balaiya; Ravi K Murthy; Kakarla V Chalam
Journal:  Mol Vis       Date:  2013-11-23       Impact factor: 2.367

8.  PKC activation by resveratrol derivatives with unsaturated aliphatic chain.

Authors:  Satyabrata Pany; Anjoy Majhi; Joydip Das
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

Review 9.  Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Alessandro Di Domizio; Patrizia Limonta
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

10.  Separation and Identification of Resveratrol Butyrate Ester Complexes and Their Bioactivity in HepG2 Cell Models.

Authors:  Ming-Kuei Shih; You-Lin Tain; Chiu-Min Cheng; Chien-Ning Hsu; Yu-Wei Chen; Hung-Tse Huang; Chi-I Chang; Chih-Yao Hou
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.